Caisse DE Depot ET Placement DU Quebec Sells 62,069 Shares of DaVita Inc. $DVA

Key Points

• Caisse de Depot et Placement du Quebec has significantly reduced its stake in DaVita Inc. by selling 62,069 shares, resulting in an 88.3% decrease in its holdings during Q1.
• DaVita's stock was recently valued at $1,254,000 in the latest SEC filing, with the company reporting earnings of $2.95 per share, exceeding analysts' expectations.
• Institutional investors own 90.12% of DaVita's stock, indicating strong institutional support, while several brokerages have set price targets for the stock between $148.00 and $169.00.

Caisse DE Depot ET Placement DU Quebec lowered its position in DaVita Inc. (NYSE:DVA - Free Report) by 88.3% in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm owned 8,200 shares of the company's stock after selling 62,069 shares during the quarter. Caisse DE Depot ET Placement DU Quebec's holdings in DaVita were worth $1,254,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also added to or reduced their stakes in the company. UMB Bank n.a. raised its stake in DaVita by 65.5% during the first quarter. UMB Bank n.a. now owns 192 shares of the company's stock worth $29,000 after acquiring an additional 76 shares in the last quarter. Copia Wealth Management acquired a new position in shares of DaVita during the fourth quarter valued at $30,000. National Pension Service boosted its stake in shares of DaVita by 74.3% in the 1st quarter. National Pension Service now owns 197 shares of the company's stock valued at $30,000 after purchasing an additional 84 shares during the last quarter. Y.D. More Investments Ltd acquired a new stake in DaVita during the 1st quarter worth $35,000. Finally, University of Texas Texas AM Investment Management Co. acquired a new stake in shares of DaVita during the first quarter worth $83,000. Institutional investors own 90.12% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have commented on DVA. Barclays lowered their target price on shares of DaVita from $169.00 to $160.00 and set an "equal weight" rating for the company in a research note on Thursday, August 7th. Wall Street Zen raised shares of DaVita from a "hold" rating to a "buy" rating in a research note on Friday, August 22nd. Finally, Truist Financial set a $148.00 price target on DaVita in a research report on Friday, August 8th. Three equities research analysts have rated the stock with a Hold rating, Based on data from MarketBeat.com, DaVita presently has an average rating of "Hold" and a consensus target price of $164.00.

Insider Buying and Selling at DaVita

In related news, insider James O. Hearty sold 2,351 shares of the company's stock in a transaction that occurred on Wednesday, July 23rd. The shares were sold at an average price of $150.00, for a total transaction of $352,650.00. Following the completion of the transaction, the insider directly owned 26,038 shares in the company, valued at $3,905,700. This represents a 8.28% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this hyperlink. Insiders own 1.50% of the company's stock.

DaVita Price Performance

DVA stock traded up $0.54 during mid-day trading on Thursday, hitting $136.51. The stock had a trading volume of 182,009 shares, compared to its average volume of 851,537. DaVita Inc. has a 52 week low of $126.07 and a 52 week high of $179.60. The firm has a market capitalization of $9.76 billion, a P/E ratio of 13.41, a P/E/G ratio of 0.99 and a beta of 1.13. The company has a current ratio of 1.39, a quick ratio of 1.34 and a debt-to-equity ratio of 23.18. The firm has a fifty day simple moving average of $139.59 and a 200 day simple moving average of $142.20.

DaVita (NYSE:DVA - Get Free Report) last issued its earnings results on Tuesday, August 5th. The company reported $2.95 earnings per share for the quarter, beating analysts' consensus estimates of $2.70 by $0.25. The firm had revenue of $3.38 billion for the quarter, compared to the consensus estimate of $3.36 billion. DaVita had a return on equity of 369.39% and a net margin of 6.35%.The company's revenue was up 6.1% compared to the same quarter last year. During the same quarter last year, the business posted $2.00 EPS. DaVita has set its FY 2025 guidance at 10.200-11.300 EPS. As a group, research analysts forecast that DaVita Inc. will post 10.76 EPS for the current year.

DaVita Company Profile

DaVita Inc provides kidney dialysis services for patients suffering from chronic kidney failure in the United States. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also offers outpatient, hospital inpatient, and home-based hemodialysis services; operates clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers.